"Tobramycin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An aminoglycoside, broad-spectrum antibiotic produced by Streptomyces tenebrarius. It is effective against gram-negative bacteria, especially the PSEUDOMONAS species. It is a 10% component of the antibiotic complex, NEBRAMYCIN, produced by the same species.
Below are MeSH descriptors whose meaning is more general than "Tobramycin".
Below are MeSH descriptors whose meaning is more specific than "Tobramycin".
This graph shows the total number of publications written about "Tobramycin" by people in Harvard Catalyst Profiles by year, and whether "Tobramycin" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
1995 | 1 | 1 | 2 |
1996 | 1 | 0 | 1 |
1998 | 1 | 1 | 2 |
1999 | 1 | 0 | 1 |
2000 | 0 | 1 | 1 |
2001 | 0 | 2 | 2 |
2002 | 0 | 1 | 1 |
2003 | 1 | 0 | 1 |
2004 | 1 | 0 | 1 |
2007 | 1 | 0 | 1 |
2008 | 0 | 2 | 2 |
2009 | 2 | 0 | 2 |
2011 | 1 | 1 | 2 |
2012 | 2 | 2 | 4 |
2014 | 1 | 1 | 2 |
2015 | 0 | 1 | 1 |
2017 | 3 | 2 | 5 |
2019 | 1 | 0 | 1 |
2021 | 1 | 0 | 1 |
2023 | 0 | 1 | 1 |
Below are the most recent publications written about "Tobramycin" by people in Profiles.
-
An Amino Acid Substitution in Elongation Factor EF-G1A Alters the Antibiotic Susceptibility of Pseudomonas aeruginosa LasR-Null Mutants. J Bacteriol. 2023 06 27; 205(6):e0011423.
-
Intraoperative Tobramycin Powder Prevents Enterobacter cloacae Surgical Site Infections in a Rabbit Model of Internal Fixation. J Orthop Trauma. 2021 01 01; 35(1):35-40.
-
Piperacillin/Tazobactam versus Tobramycin-Based Antibiotic Prophylaxis for Type III Open Fractures. Surg Infect (Larchmt). 2020 Feb; 21(1):23-28.
-
Surgical Site Infections following Spine Surgery for Non-idiopathic Scoliosis. J Pediatr Orthop. 2017 Dec; 37(8):e476-e483.
-
An Antipersister Strategy for Treatment of Chronic Pseudomonas aeruginosa Infections. Antimicrob Agents Chemother. 2017 12; 61(12).
-
Pharmacological Inhibition of the Pseudomonas aeruginosa MvfR Quorum-Sensing System Interferes with Biofilm Formation and Potentiates Antibiotic-Mediated Biofilm Disruption. Antimicrob Agents Chemother. 2017 12; 61(12).
-
Reducing Second Gram-Negative Antibiotic Therapy on Pediatric Oncology and Hematopoietic Stem Cell Transplantation Services. Infect Control Hosp Epidemiol. 2017 09; 38(9):1039-1047.
-
Acute Kidney Injury After First-Stage Joint Revision for Infection: Risk Factors and the Impact of Antibiotic Dosing. J Arthroplasty. 2017 10; 32(10):3120-3125.
-
Invitro Apramycin Activity against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Diagn Microbiol Infect Dis. 2017 Jun; 88(2):188-191.
-
Retinal Branch Artery Embolization Following Hyaluronic Acid Injection: A Case Report. Aesthet Surg J. 2016 Jul; 36(7):NP219-24.